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SUMMARY
Nasal obstruction is a frequent condition in patients with obstructive sleep apnoea (OSA). Nasal obstruction leads to mouth breathing, which 
is thought to destabilise the upper airway to aggravate the condition. Three conditions could be considered as the cause of the nasal breathing 
obstruction: anatomical conditions of the nose (septum deviation, hypertrophy of the inferior turbinates), chronic rhinosinusitis (CRS) and 
chronic nasal inflammation caused by allergic rhinitis or non-allergic cellular rhinitis. In this prospective study, we present an evaluation of 
all these possible rhino-sinusal aspects in OSA patients to correlate different nasal pathologies with nasal obstruction. Fifty patients with a 
diagnosis of OSA were enrolled in the study. In 70% of OSA patients, nasal obstruction was confirmed by clinical evaluation and rhinoma-
nometry testing. Normal rhino-sinus aspects were present in only 20% of OSAS patients, whereas one or more pathological rhino-sinus 
conditions were present in the remaining 80%. The percentage of OSA patients with a diagnosis of allergic rhinitis and non-allergic rhinitis 
was 18% and 26% respectively. Non-allergic rhinitis with neutrophils (NARNE) was the most frequent type of cellular rhinitis diagnosed 
in OSA patients (20% of cases). The results of the present study support and extend the observation that rhinitis is present in OSA patients. 
Mucosal inflammation caused by these conditions could be the cause of  upper airway patency impairment inducing nasal mucosa swelling.
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RIASSUNTO 
L’ostruzione nasale è una condizione frequentemente riportata in pazienti con sindrome delle apnee ostruttive del sonno (OSAS). L’ostru-
zione nasale porta alla respirazione orale, che si pensa possa destabilizzare le vie aeree superiori e aggravare l’OSAS. Tre condizioni 
potrebbero essere considerate come la causa dell’ostruzione respiratoria nasale: condizioni anatomiche nasali (deviazione del setto, 
ipertrofia dei turbinati inferiori), rinosinusite cronica (CRS) e infiammazione nasale cronica causata da rinite allergica o riniti non aller-
giche a cellularità. In questo studio prospettico presentiamo una valutazione di tutti questi possibili aspetti naso-sinusali in pazienti con 
OSAS al fine di correlare le diverse patologie nasali con l’ostruzione respiratoria nasale. Cinquanta pazienti con una diagnosi di OSAS 
sono stati arruolati nello studio. Nel 70% dei pazienti con OSAS, l’ostruzione nasale è stata confermata dalla valutazione clinica e dal 
test della respirazione con rinomanometria. Normali aspetti naso-sinusali erano presenti solo nel 20% dei pazienti con OSAS, mentre una 
o più condizioni patologiche naso-sinusali erano presenti nel restante 80%. L’incidenza di pazienti con OSAS con una diagnosi di rinite 
allergica e rinite non allergica era rispettivamente del 18% e del 26%. La rinite non allergica con neutrofili (NARNE) è stata la  diagnosi 
più frequente nei pazienti con OSAS (20% dei casi). I risultati del presente studio supportano ed estendono l’osservazione che condizioni 
rinitiche sono presenti nei pazienti con OSAS. L’infiammazione della mucosa causata da queste condizioni potrebbe essere la causa della 
compromissione delle vie aeree superiori inducendo edema della mucosa nasale.
PAROLE CHIAVE: Sindrome delle apnee ostruttive del sonno • Ostruzione nasale • Riniti allergiche • Riniti non allergiche • Cleareance 
mucociliare nasale
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Introduction
Obstructive sleep apnoea (OSA) is a clinical entity char-
acterised by recurring episodes of apnoea and/or hypo-
pnoea during sleep due to a total or partial collapse of 
the upper airway 1-3. OSA is characterised by night snor-
ing with excessive daytime sleepiness and is commonly 
associated with a reduced quality of life, cardiovascular 
diseases, increased healthcare utilisation, motor vehicle 
accidents and decreased of cognitive performance 3-5.
Multilevel anatomical obstruction may play a role in OSA 3-7. 
Nasal obstruction is frequently reported in these patients 5-8. 
Various authors have supported the theory that nasal ob-
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struction is a contributing factor in the pathogenesis of 
OSA despite numerous controversies 6-10. Nasal obstruc-
tion leads to mouth breathing, which is thought to desta-
bilise the upper airway and aggravate OSA 7-9. Moreover, 
nasal breathing obstruction might represent a factor influ-
encing the clinical history of this disease as well as the 
patient’s compliance with CPAP 8-11. 
What is the cause of nasal obstruction in OSA patients? 
Based on current knowledge about these patients, three 
conditions could be considered as the cause of the nasal 
breathing obstruction: anatomical conditions of the nose 
(septum deviation, hypertrophy of the inferior turbinates), 
chronic rhinosinusitis (CRS) and, as recently reported, 
nasal inflammation 5-13. 
The effect of anatomical abnormalities of the nose on the 
sleep disorders has been analysed by different authors, 
who confirm an  improvement in the number of apnoea/
hypopnoea episodes following surgical correction of na-
sal abnormalities (septoplasty or turbinoplasty) 6-10. It has 
also been well established that CRS causes impaired sleep 
quality and represents a risk factor for sleep apnoea and 
daytime sleepiness 14 15. 
Recently, Zheng et al.  16 reviewed the literature and 
suggested a possible correlation between rhinitis and 
nasal obstruction in OSA patients. Today, it is gen-
erally accepted that the chronic nasal inflammation 
present in allergic and non-allergic rhinitis is a cause 
of increased nasal airway resistance due to mucosal 
swelling  9-13. Therefore, nasal inflammation caused 
by these conditions may be a factor influencing na-
sal mucosa swelling and obstruction in OSA patients 
during sleep 10-13 16. However, these conditions cannot 
be identified from clinical assessment, nasal symptom 
scores or rhinomanometry, and need to be studied us-
ing specific tests such as the skin prick test and nasal 
cytology 9-12 17. 
In our opinion, the conditions responsible for nasal ob-
struction should not be considered separately in OSA 
patients but rather as a whole, since they may overlap 
and contribute in different ways to nocturnal nasal ob-
struction. No study has so far analysed the incidence 
of these different nasal conditions (AR, NAR, CRS) in 
OSA patients and their relationship to nasal obstruction. 
According to the above observations, we designed a 
prospective study with the subsequent aims: 1) perform 
an extensive evaluation of all rhino-sinusal aspects in 
OSA patients; 2) characterise the presence of allergic 
rhinitis (AR) and non-allergic cellular rhinitis. 3) cor-
relate the different rhino-sinusal pathologies with nasal 
obstruction.
Materials and methods 
Subjects
Patients affected by OSA were enrolled in our prospective 
clinical observational study at the “Organi di Senso” De-
partment of the “Sapienza” University in Rome between 
December 2014 and January 2018. 
Subjects eligible for the study were initially selected 
from patients referred to our Department with suspect-
ed OSA. All these patients underwent polysomnogra-
phy (PSG) for diagnosis of this pathology. In accord-
ance with the American Academy of Sleep Medicine 
(AASM), diagnosis and classification of OSA patients 
were performed on the basis of the apnoea + hypopnoea 
index (AHI) index. Patients were classified as normal 
(AHI was < 5/h), mild (AHI ≥ 5 and < 15 plus typical 
symptomatology), moderate (AHI  ≥  15 and  <  30) and 
severe (AHI ≥ 30) 18 19. 
Patients who had undergone surgery to the nose and/or 
rhino-sinusal surgery were excluded from the study. No 
patients were undergoing treatment with a CPAP device 
at home. Patients who were receiving topical or systemic 
steroids or other nasal therapies were also excluded from 
the study.
Clinical data, including height and weight, in order to cal-
culate body mass index (BMI), medical history, tobacco 
use and a list of current medications were initially col-
lected for each patient. 
Nasal obstruction and possible presence of the three situa-
tions believed to cause OSA (nasal abnormalities, chronic 
sinusitis, allergic and non allergic cellular rhinitis) were 
investigated in all patients.
Nasal respiratory obstruction
The diagnosis of nasal respiratory obstruction was per-
formed by clinical evaluation (self-reported sensation of 
nocturnal nasal obstruction and dry mouth upon awaken-
ing) and a rhinomanometry test. Anterior rhinomanom-
etry is widely used to evaluate nasal resistance. It has been 
reported in the literature 20 that the mean total resistance 
in normal subjects ranges between 0.10 and 0.3 Pa/cm3/s, 
with a mean of 0.25 Pa/cm3/s. For this reason, total nasal 
airway resistance > 0.3 Pa/cm3/s was considered patho-
logical. 
Nasal abnormalities 
All patients were submitted to ENT physical examina-
tion with nasal endoscopy (2.7 mm 0° rigid endoscope) 
to evaluate the features of nasal structures (septum devi-
ation, hypertrophy of the inferior turbinates) and detect 
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anatomical abnormalities responsible for nasal obstruc-
tion.
Chronic rhinosinusitis
A diagnosis of CRS was made according to the EPOS 
classification of rhinosinusitis  21 which considers pa-
tients with two or more signs and symptoms (bilateral 
nasal obstruction, nasal discharge, facial pain/ headache, 
subjective olfactory dysfunction) for 12 or more weeks, 
without complete resolution. Any rhinosinusal patholo-
gies (such as nasal polyposis, aspects of chronic rhinosi-
nusitis, nasal infection) were also investigated during 
nasal endoscopy.
Moreover, all patients underwent CT scan of rhinosi-
nusal structures (axial, coronal and sagittal projections, 
without the use of intravenous contrast) at the same time 
as the ENT examination to confirm or exclude CRS. 
Allergic and non-allergic cellular rhinitis (AR and NAR)
According to ARIA diagnostic criteria 22 patients with at 
least 2 of the allergic rhinitis (AR) symptoms were in-
vestigated for AR (suggestive symptomatology according 
to Skin prick test/IgE positivity) and non-allergic cellular 
rhinitis (NAR). Cellular rhinitis was diagnosed by nasal 
cytology in patients with a clinical suggestive history of 
AR, but without allergic sensitisation (Skin prick test/IgE 
positivity) 11 22-24.
Patients with rhinopathy were subdivided on the basis of 
the prick test and of nasal cytology into subjects with AR 
or with NAR 11 22-24. Cellular forms were further sub-divid-
ed on the basis of cytotype 11 24.
In accordance with the European Academy of Allergy and 
Clinical Immunology, standardised allergen panels were 
employed to detect an IgE-mediated allergic response in 
all CVID patients 22 23. The allergen panel consisted of the 
following: house dust mites (Dermatophagoides farinae 
and pteronyssinus), cat and dog hair, grasses mix, com-
posite mix, parietaria judaica, birch, hazel tree, olive tree, 
alternaria tenuis, cladosporium and aspergilli mix; the 
concentration of allergen extracts was 100 IR/mL (Stal-
lergenes, Milan, Italy). Sensitisation was considered pre-
sent when the diameter of local reaction was equal to or 
greater than 3 mm 22 23.
Scrapings of the nasal mucosa were placed on a micro-
scope slide,  fixed for air dry and stained by the May-
Grunwald-Giemsa method  11  24. The semi-quantitative 
analysis proposed by Meltzer et al. 25 was used to evaluate 
nasal cytology. 
According to the semi-quantitative analysis and to the re-
sults of skin prick tests, patients were classified as nor-
mal or as having AR or NAR 11 22-25. NAR subjects, also 
defined as cellular rhinitis, were further subdivided into 
NARNE (neutrophils  >  50% with absent spores and 
bacteria); NARES (eosinophils > 20%); NARMA (mast 
cells > 10%); NARESMA (eosinophils > 20% and mast 
cells > 10%) 11 24 25.
Diagnosis of rhino-sinusal pathologies 
Byomparing results of the above mentioned tests, differ-
ent conditions were diagnosed: isolated nasal abnormali-
ties, chronic rhinosinusitis (CRS),AR), AR + CRS, NAR 
and NAR + CRS. Each of these conditions was correlated 
with the presence of nasal obstruction.
Statistical analysis
A Student’s T test and χ2 test were employed to evaluate 
the significance of multiple factors. A p value of < 0.05 
was taken as the threshold of statistical significance. This 
research study was performed in accordance with the 
principles of the Declaration of Helsinki and approved by 
the local Ethics Committee of the University ‘‘Sapienza’’ 
of Rome. All patients gave written informed consent for 
the PSG, CT scan and other rhinologic tests of the study.
Results
55 patients with a diagnosis of OSA were enrolled in the 
study. The mean age of the study group was 55.2 years 
(range 35-79): 33 subjects were male and 17 were female.
The clinical characteristics of the study group are reported 
in Table I.
In 35 (70%) patients with OSA, nasal obstruction was 
confirmed by clinical evaluation and rhinomanometry 
testing (Table  I). No difference emerged between OSA 
subgroups and the incidence of nasal obstruction using the 
chi square test (p > 0.5 in each case). This was confirmed 
by regression analysis between AHI index and mean na-
sal airway resistance calculated with the rhinomanometry 
test (p = 0.7) (Fig. 1). 
The diagnostic protocol used in this study showed that 
normal rhino-sinus aspects were present in only 20% of 
OSA patients, whereas one or more pathological rhino-
sinus conditions were present in the remaining 80%. 
The incidence of the different rhino-sinus pathologies 
present in OSA patients is reported in Table II. Interest-
ingly, the incidence of OSA patients with a diagnosis of 
AR and NAR was 18% and 26%, respectively. 
In patients with a diagnosis of AR or NAR, mean AHI did 
not differ from those without rhinitis diagnosis (p > 0.05 
in each case; Fig. 2).
In 82.5% of patients suffering from a pathological rhino-
sinus condition, nasal obstruction was present. There was 
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a significant difference between normal and pathological 
subjects regarding nasal obstruction (p = 0.004).
Analysing the different pathological rhino-sinus conditions 
regarding the simultaneous presence or absence of nasal 
obstruction, interesting aspects emerged (Table II): 100% 
of patients with AR, CRS and AR+CRS showed nasal ob-
struction, whereas this condition was present in 92.3% of 
patients suffering from NAR. Different from these inflam-
matory conditions, only 60% of patients with isolated nasal 
abnormalities (nasal deviation, inferior turbinate hypertro-
phy etc.) had a diagnosis of nasal obstruction. 
Table III displays a subdivision of different pathological 
rhino-sinus conditions according to Nasal Cytological 
Outcomes classification. Non-allergic rhinitis with neu-
Table I. Clinical characteristics of the study group.
OSA patients 
50 pts
Mean age 55.2 years (range 35-79 years old)
Mild OSA: 54.5
Moderate OSA: 55.1
Severe OSA: 57.4
Sex 33 male 
17 female
BMI (mean value) 32.5
OSA severity Mild OSA
15 pts (mean AHI = 10.9)
Moderate OSA
18 pts (mean AHI = 21.5)
Severe OSA
17 pts (mean AHI = 42.6)
NASAL OBSTRUCTION
(Clinical evaluation + 
rinomanometry) 
Mild OSA
Moderate OSA
Severe OSA
35 pts
10 pts
11 pts
14 pts
70% 
20%
22%
28%
Fig. 1. Regression analysis between AHI index and mean nasal airway re-
sistance calculated with the rhinomanometry test (p = 0.7).
Fig. 2. Box plot of mean AHI value of patients without rhinitis and patients 
with allergic rhinitis and non-allergic rhinitis diagnosis.
Table II. Different rhino-sinusal pathologies present in OSA patients.
OSA patients
(number of pts - percentage) 
OSA patients with nasal 
obstruction
OSA patients without nasal 
obstruction
Number of patients 50 35 (70%) 15 (30%)
Normal rhino-sinusal aspects 10 (20%) 2 (20%) 8 (80%)
Pathological rhino-sinusal aspects
Isolated nasal abnormalities  
(nasal septum deviation, inferior turbinate hypertrophy)
Chronic rhinosinusitis (CRS)
Allergic rhinitis (AR)
CRS + AR
Non-allergic rhinitis (NAR)
NAR + CRS
40 (80%)
15 (30%)
3 (6%)
4 (8%)
5 (10%)
13 (26%)
-
33 (82.5%)
9 (60%)
3 (100%)
4 (100%)
5 (100%)
12 (92.3%)
-
7 (15.5%)
6 (40%)
-
-
-
1 (7.7%)
-
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trophils (NARNE) was the most frequent NAR diagnosed 
in OSA patients (20% of cases). In patients diagnosed 
with AR, numerous neutrophils and eosinophils, partially 
degranulated, were evident at cytology, whereas in all 
those diagnosed with CRS cytological characteristics of 
infective rhinitis were present.
Discussion
There is evidence showing that nasal obstruction could 
contribute to the pathogenesis of OSA, decrease the quali-
ty of life in OSA patients, contribute to snoring and repre-
sent an obstacle for effective treatment with CPAP 6-11 26-28.
What is the cause of nasal obstruction in OSA patients? A 
systematic evaluation of nasal obstruction remains chal-
lenging due to the high number of factors that contrib-
ute to nasal obstruction 6 8 10. Currently, nasal obstruction 
evaluation in OSA patients in most medical environments 
is limited to anterior rhinoscopy: this allows evaluation of 
anterior septal deviation, internal nasal valve angle and 
inferior turbinate size, but fails to identify other factors 
that could play a role in nasal obstruction  6-11. In addi-
tion, characteristics of the anterior nasal cavity frequently 
do not correlate with the patient’s symptoms and/or nasal 
breathing. Patients often complain of nasal obstruction 
despite no objective signs of anatomical abnormalities in 
the nasal cavity when examined with anterior rhinoscopy 
and/or nasal endoscopy 11 16. 
Other aetiologies for nasal obstruction such as chronic si-
nusitis or inflammatory problems such as AR and/or non-
allergic cellular rhinitis, could be the reason why noctur-
nal nasal breathing is absent 11 16.
In our observational study, it emerged that 70% of OSA 
patients displayed nasal respiratory obstruction. Normal 
rhino-sinusal aspects were present in only 20% of OSA 
patients examined, whereas one or more pathological 
rhino-sinusal conditions were present in 80% of enrolled 
patients. It is interesting to note that only 30% of these 
patients had isolated anatomical abnormalities, 6% had 
chronic rhinosinusitis, 18% AR and 26% NAR. These 
corroborate the results reported by Shadan et al.  29 who 
employed nasal cytology as a marker of clinically silent 
inflammation in a group of 38 OSA patients, diagnosing 
AR in 37% and NAR in 21% of subjects.
Regarding the cause of nasal obstruction in OSA patients, 
it should be noted that 95.4% of patients with nasal in-
flammatory conditions such as AR or NAR, suffered from 
nocturnal respiratory obstruction. In contrast, 40% of 
patients with isolated nasal abnormalities did not suffer 
from nasal obstruction. 
Some observational studies have shown how the nasal 
congestion induced by AR is an important factor in sleep 
impairment  12 16 30. One large population-based study in-
volving about 5,000 adults demonstrated that individuals 
reporting frequent nasal congestion (5 nights/month) due 
to allergy were almost twice as likely to have moderate-
to-severe SDB than individuals without nasal congestion 
due to allergy 15. Moreover, the incidence of AR among 
patients with OSA was recently estimated to be between 
11.7% and 27.1% with no significant differences in sleep-
ing parameters between allergic and non-allergic pa-
tients 10. 
The mechanism through which AR causes poor quality of 
sleep and daytime fatigue is not entirely clear, but several 
factors are believed to be involved. Inflammatory mediators 
such as interferon- (IFN-) gamma, tumour necrosis factor- 
(TNF-) alpha, interleukin- (IL-) 1b, IL-4, IL-10, postural 
changes and certain therapeutic agents, such as antihista-
mines, may have a direct impact on sleep regulation 12 13 16. 
However, like AR, non-allergic cellular rhinitis should 
also be considered among the possible causes of nasal 
congestion due to inflammation of the mucosa 11-13.
A high incidence of NAR of 28.7% in OSA has been re-
cently reported by Zheng et al.  12 using validated ques-
tionnaires and skin prick tests. The patients in this study 
with NAR had lower average arterial oxygen saturation 
and minimal arterial oxygen saturation, compared with 
subjects categorised as no-rhinitis.
Table III. Nasal cytological outcomes.
Nasal cytology Cytological characteristics Total of patients
Allergic rhinitis
(skin prick test +)
Numerous neutrophils and eosinophils, partially degranulated 9 (18%)
Non allergic cellular rhinitis 
NARNE
NARMA
NARES
NARESMA
Neutrophils > 50% with absent spores and bacteria
Mast cells > 10%
Eosinophils > 20%
Eosinophils > 20% and mast cells > 10%
13 (26%)
10 (20%)
-
2 (4%)
1 (2%)
Infective* Numerous neutrophils and bacteria 3 (6%)
*: patients with cytological characteristics of infective rhinitis was the same with a CRS diagnosis.
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According to the recent ARIA classification, in order to 
obtain a more precise classification of NAR, nasal cytol-
ogy tests should be performed in patients with sugges-
tive history of AR, but without allergic sensitisation (Skin 
prick test/IgE positivity) 11 22-24. 
Using these tests, Gelardi et al. 11 were the first to demon-
strate a subclinical nasal inflammation in patients with OSA 
in CPAP treatment. They showed that at cytology examina-
tion 9 patients (28.1%) had aspects of NARNE, 6 (18.7%) of 
NARES and 4 (12.5%) of NARESMA, whereas 5 (15.6%) 
patients showed cellular signs of AR with numerous neu-
trophils and eosinophils, partially degranulated: finally in 8 
(25%) patients the cytologic signs of rhinosinusitis charac-
terised by numerous neutrophils and the presence of bacteria.
Using the same diagnostic protocol as Gelardi et al. 11, in 
our study group of OSA patients NARNE was present in 
20% of cases, whereas NARES and NARESMA was seen 
in 4% and 2%, respectively.
Different from other studies, patients with a diagnosis of 
AR or NAR did not seem to have a mean AHI that was 
significantly different from that of patients not diagnosed 
with rhinitis 12 16 (p > 0.05 in all cases). Similar results have 
been reported by Kramer et al. 10 who found no significant 
differences in sleeping behaviour or polysomnography 
parameters comparing allergic and non-allergic patients. 
The results of the present study support and extend the 
observation that rhinitis is present in OSA patients 11 12 16. 
Mucosa inflammation caused by these conditions may 
further compromise upper airway patency by inducing 
nasal mucosa swelling. 
In our opinion, inflammatory conditions such as AR and/
or cellular rhinitis should be evaluated in OSA patients to 
avoid unnecessary surgical procedures, re-establish nor-
mal nasal function and improve compliance with eventual 
CPAP treatment  11  29-32. Notwithstanding, further studies 
are necessary to investigate inflammation mediators in na-
sal mucosa of OSA patients and correlate these with the 
presence of nasal obstruction and the severity of OSA. 
Conclusions
One or more pathological rhino-sinusal conditions were 
present in 80% of OSA patients evaluated in this study. 
The incidence of OSA patients with a diagnosis of AR 
and NAR was 18% and 26%, respectively. A diagnosis 
of AR or NAR does not seem to correlate with severity 
of AHI.
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